BioCentury
ARTICLE | Company News

Visterra, U.S. Department of Health and Human Services infectious news

October 12, 2015 7:00 AM UTC

HHS’s Biomedical Advanced Research and Development Authority (BARDA) awarded Visterra a five-year contract worth up to $204.5 million to develop VIS410 to treat influenza A. The contract will fund pr...